Women’s health & beauty supplements market is projected to grow from $14.1 billion in 2025 to $28.3 billion by 2035, expanding at a CAGR of 7.2% during 2026–2035. The market growth is being strongly supported by the rising focus on preventive healthcare, nutritional wellness, and beauty-from-within product adoption among women across all age groups. A major macro driver accelerating demand is the growing burden of micronutrient deficiency among women worldwide. According to the World Health Organization, 30.7% of women aged 15–49 globally were affected by anaemia in 2023, while 35.5% of pregnant women suffered from anaemia, highlighting the urgent need for iron, folate, multivitamin, and mineral supplementation. This directly supports demand for vitamins & minerals supplements, making it the largest and fastest-growing product segment within the market.

Smart waste management market is projected to grow from $4.08 billion in 2025 to $16.51 billion by 2035, registering a CAGR of 15.0% during the forecast period (2026–2035). The market is witnessing strong momentum driven by rapid urbanization, rising waste generation, and increasing adoption of digital technologies such as IoT and AI across municipal infrastructure.

Serology test market is projected to grow from $6.5 billion in 2025 to $10.6 billion by 2035, expanding at a CAGR of 5.2% during the forecast period. Growth in the market is primarily driven by the rising global burden of infectious and chronic diseases, increasing demand for diagnostic screening, and expansion of laboratory infrastructure across emerging economies.

SaaS Customer Relationship Management (CRM) market is projected to grow from $82 billion in 2025 to $210 billion by 2035, registering a CAGR of 9.8% during the forecast period. The market expansion is being driven by the rapid digital transformation of enterprises and the increasing adoption of cloud-based business applications across industries. A key macroeconomic driver influencing market growth is the accelerating digital connectivity worldwide. According to the International Telecommunication Union (ITU), global internet penetration reached 67% of the world population in 2023, with over 5.4 billion people connected. This surge in digital connectivity is enabling enterprises to adopt cloud-native platforms, including SaaS CRM systems, to manage customer interactions, automate workflows, and enhance data-driven decision-making. As organizations increasingly shift toward digital-first strategies, CRM solutions are becoming essential tools for managing omnichannel customer engagement.

Radiotherapy market is projected to grow from $8.08 billion in 2025 to $13.65 billion by 2035, expanding at a CAGR of 6.0% during the forecast period. This growth is primarily driven by the rising global burden of cancer and increasing adoption of advanced radiotherapy technologies such as proton therapy and image-guided radiotherapy. A major macro driver influencing the market is the rapid increase in cancer incidence globally. According to the World Health Organization, cancer accounted for nearly 10 million deaths in 2022, making it one of the leading causes of mortality worldwide. Furthermore, the WHO estimates that 1 in 5 people will develop cancer during their lifetime, significantly increasing the demand for radiotherapy, which is required in approximately 50–60% of all cancer cases as part of treatment protocols.

Quality management software market is projected to grow from $8.2 billion in 2025 to $22.1 billion by 2035, expanding at a CAGR of 10.4% during the forecast period (2026–2035). The market growth is strongly driven by the rising need for regulatory compliance, digital transformation across industries, and increasing complexity in global supply chains.

Periodontal treatment market is projected to grow from $12.73 billion in 2025 to $33.61 billion by 2035, registering a CAGR of 10.2% during the forecast period (2026–2035). The market expansion is primarily driven by the rising global burden of oral diseases and increasing awareness regarding preventive dental care. According to the World Health Organization (WHO), severe periodontal (gum) disease affects nearly 19% of the global adult population, representing over 1 billion cases worldwide. Additionally, WHO estimates that oral diseases impact 3.5 billion people globally, highlighting a significant unmet need for effective periodontal treatment solutions. The increasing prevalence of risk factors such as diabetes, smoking, and aging populations further intensifies demand for advanced periodontal therapies, thereby supporting market growth.

Pediatric drugs market is projected to grow from $120 billion in 2025 to $232 billion by 2035, expanding at a CAGR of 6.8% during the forecast period (2026–2035). The market growth is strongly driven by the rising burden of pediatric diseases globally, increasing regulatory support for pediatric drug development, and advancements in biologics and targeted therapies. A key macro driver influencing the market is the growing pediatric population and disease prevalence. According to the World Health Organization (WHO), children under 18 years account for nearly 30% of the global population, with infectious diseases such as pneumonia and diarrhea remaining leading causes of mortality in children under five. 

Passenger information system (PIS) market is projected to grow from $37.60 billion in 2025 to $92.30 billion by 2035, expanding at a robust CAGR of 13.5% during the forecast period (2026–2035). The market growth is strongly driven by the rapid expansion of smart transportation infrastructure and increasing investments in intelligent mobility solutions worldwide.

Irritable bowel syndrome (IBS) treatment market is projected to grow from $12.4 billion in 2025 to $20.5 billion by 2035, expanding at a CAGR of 5.2% during the forecast period. The market growth is driven by the increasing global burden of gastrointestinal disorders, rising awareness of functional bowel diseases, and continuous innovation in targeted therapies. A key macro driver supporting this growth is the rising prevalence of digestive disorders worldwide. According to the World Health Organization (WHO), gastrointestinal diseases impact a substantial share of the global population, with functional disorders such as IBS affecting approximately 10–15% of adults globally.